. Thin and thick blood smears and results of the immunochromatographic test (Binax NOW malaria tests; Binax, Portland, ME, USA) were negative. The patient recovered without sequelae and was discharged 6 days after admission.
At admission, chikungunya virus-specifi c immunoglobulin (Ig) G and IgM were not detected by indirect immunofl uorescence tests (2) . IgG, but not IgM, specifi c for DENV was detected by an immunochromatic test (Panbio Dengue Duo Cassette; Biotrin, Lyon, France) and confi rmed by ELISA (PanBio dengue duo test). However, DENV RNA was demonstrated in serum by using 4 reversetranscription-PCR (RT-PCR)-based assays: a positive result in a fl avivirus universal assay (3), a positive result in a DENV-1-4 real-time RT-PCR (4), a positive result in a DENV-3-specifi c RT-PCR, and a negative result in a specifi c RT-PCR for DENV-1, -2, and -4 (4). The concomitant fi nding of DENV RNA and IgG against DENV suggests the patient had dengue infection before this episode.
DENV-3 viremia was confi rmed by sequencing a 547-nt region of the envelope gene (GenBank accession no. FJ587232, nt 852-1398 referring to the H87 DENV-3 prototype strain). Our sequence aligned with homologous DENV-3 sequences retrieved from GenBank and used for phylogenetic analysis (Figure) . Our patient, in whom classic dengue fever was diagnosed, was infected with a strain that belonged to genotype III most closely related to strains isolated in Singapore, Taiwan, Sri Lanka, India, and Saudi Arabia. Its closest relatives were the strain from Saudi Arabia isolated in 2004 and another strain claimed in ProMED by Japanese researchers to have been isolated in 2008 from a Japanese traveler returning from Côte d'Ivoire (6) . Therefore, this strain is likely to have originated in the Middle East, the Indian subcontinent, or Southeast Asia rather than in Central or South America.
In Africa, most data on epidemic or endemic dengue activity originate in East Africa. Dengue fever was seldom reported in West Africa. In 2000, DENV-1 was isolated from a French soldier in Côte d'Ivoire (7). More recently, an outbreak caused by DENV-2 occurred in Gabon in West Africa (8) Figure. Phylogenetic analysis of selected dengue virus type 3 (DENV-3) sequences. The main genotypes are indicated using roman numerals at the node of the lineage. Sequence identifi cation is as follows: country of origin, strain name, year of isolation/detection. The sequence determined in our study is underlined and designated by an arrow. Phylogenetic studies were conducted by using MEGA version 2.1 (5). Genetic distances were calculated with the Kimura 2-parameter method at the nucleotide level. Phylogenetic trees were constructed using the neighbor-joining method. The robustness of the nodes was tested by 500 bootstrap replications. The tree was rooted with DENV-1, DENV-2, and DENV-4 sequences. Scale bar indicates nucleotide substitutions per site.
DENV-3 strains recently caused unexpected outbreaks of dengue hemorrhagic fever in Sri Lanka, East Africa, and Latin America (9) .
The case presented here demonstrates that epidemics may be undetected or unidentifi ed until diagnosis is assessed in another country from a returning infected visitor, thus drawing attention to an unidentifi ed potential epidemic situation. This situation can be unraveled by a clinician who considers geographic factors in the diagnostic workup and has access to and uses appropriate laboratory capacity to diagnose imported infections. At the time dengue was diagnosed in this patient, cases of yellow fever were reported in the same location of Côte d'Ivoire (Abidjan) (5), illustrating concomitant circulation of 2 viruses in which dengue may have remained undetected in the absence of a laboratory-confi rmed case in the traveler's home country. Therefore, this case reinforces the utility of travelers as sentinels for infectious diseases as previously reported (10) . Our fi ndings reiterate the need for technologic transfer of PCR-based direct diagnostics to reference centers in areas where emergence is likely. These efforts also should embrace serology and encourage close collaboration with world reference centers for confi rmation and characterization (10) .
